We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$128M
AUM Growth
-$21.3M
Cap. Flow
-$12.5M
Cap. Flow %
-9.73%
Top 10 Hldgs %
52.36%
Holding
99
New
13
Increased
31
Reduced
37
Closed
15

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$1.22M
2
ISRG icon
Intuitive Surgical
ISRG
+$1.22M
3
THC icon
Tenet Healthcare
THC
+$1.19M
4
RDNT icon
RadNet
RDNT
+$1.18M
5
CVRX icon
CVRx
CVRX
+$967K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$2.6M
2
GILD icon
Gilead Sciences
GILD
+$1.99M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.43M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$1.34M
5
HCAT icon
Health Catalyst
HCAT
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 99.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMMT icon
26
Summit Therapeutics
SMMT
$10.4B
$1.34M 1.04%
69,240
+39,240
+131% +$787K
SPRY icon
27
ARS Pharmaceuticals
SPRY
$509M
$1.26M 0.98%
100,205
-5,802
-5% -$69.8K
LEGN icon
28
Legend Biotech
LEGN
$3.59B
$1.22M 0.95%
35,965
+6,165
+21% +$221K
THC icon
29
Tenet Healthcare
THC
$20.5B
$1.21M 0.94%
+9,000
New +$1.19M
BMY icon
30
Bristol-Myers Squibb
BMY
$133B
$1.19M 0.93%
19,500
-24,500
-56% -$1.43M
INSM icon
31
Insmed
INSM
$21.4B
$1.16M 0.9%
15,230
+7,859
+107% +$601K
SWTX
32
DELISTED
SpringWorks Therapeutics
SWTX
$1.12M 0.87%
25,325
+19,825
+360% +$913K
ZLAB icon
33
Zai Lab
ZLAB
$2.06B
$1.08M 0.84%
29,920
-14,880
-33% -$458K
BOLD
34
Boundless Bio
BOLD
$56.2M
$1.02M 0.8%
678,574
– –
DXCM icon
35
DexCom
DXCM
$31.5B
$1.02M 0.8%
+15,000
New +$1.22M
BPMC
36
DELISTED
Blueprint Medicines
BPMC
$994K 0.77%
11,235
-1,325
-11% -$129K
RDNT icon
37
RadNet
RDNT
$5.02B
$994K 0.77%
+20,000
New +$1.18M
TARS icon
38
Tarsus Pharmaceuticals
TARS
$2.58B
$886K 0.69%
17,250
-3,050
-15% -$151K
FOLD
39
DELISTED
Amicus Therapeutics
FOLD
$878K 0.68%
107,585
-28,035
-21% -$259K
PHR icon
40
Phreesia
PHR
$663M
$869K 0.68%
+34,000
New +$924K
CVRX icon
41
CVRx
CVRX
$137M
$838K 0.65%
+68,500
New +$967K
ONC
42
BeOne Medicines Ltd
ONC
$32.8B
$797K 0.62%
2,927
+917
+46% +$214K
PCVX icon
43
Vaxcyte
PCVX
$7.81B
$794K 0.62%
21,040
+2,090
+11% +$167K
CYTK icon
44
Cytokinetics
CYTK
$10.5B
$726K 0.57%
18,068
-6,432
-26% -$296K
ICLR icon
45
Icon
ICLR
$12.6B
$700K 0.54%
+4,000
New +$775K
VERA icon
46
Vera Therapeutics
VERA
$2.3B
$681K 0.53%
28,348
+22,648
+397% +$728K
CLOV icon
47
Clover Health Investments
CLOV
$2.2B
$657K 0.51%
183,000
-92,000
-33% -$369K
ELV icon
48
Elevance Health
ELV
$81.5B
$652K 0.51%
+1,500
New +$602K
QURE icon
49
uniQure
QURE
$3.03B
$610K 0.47%
57,550
-13,950
-20% -$196K
MLTX icon
50
MoonLake Immunotherapeutics
MLTX
$1.57B
$590K 0.46%
15,108
-8,579
-36% -$370K
1
2
3 4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, Sectoral Asset Management held 99 positions worth $128M, down 14% from $150M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sectoral Asset Management withdrew a net $12.5M in Q1 2025, closing 15 positions and reducing 37 holdings. Its most notable exit was Sarepta Therapeutics, an estimated $1.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in DexCom worth $1.02M.

  • Sectoral Asset Management's largest Q1 2025 buy was DexCom: 15,000 shares worth $1.02M.
  • Sectoral Asset Management added most to Intuitive Surgical in Q1 2025, an estimated $1.22M increase.
  • Sectoral Asset Management's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $2.6M.
  • Sectoral Asset Management fully exited Sarepta Therapeutics in Q1 2025, selling an estimated $1.34M.
  • Sectoral Asset Management's ten largest holdings make up 52% of its $128M portfolio in Q1 2025.
  • Sectoral Asset Management opened 13 new positions and closed 15 in Q1 2025.
  • Sectoral Asset Management's portfolio value fell 14% quarter-over-quarter to $128M.

Based on Sectoral Asset Management's 13F filing for Q1 2025, filed 15 May 2025.